IVAX Launches Heliocare(R), New UV Sun Protection Capsule

MIAMI, Dec 15, 2005 (BUSINESS WIRE) -- IVAX Corporation (IVX) (UK:IVX) (WSE:IVX) announced today the launch of Heliocare(R), a new oral nutritional antioxidant supplement capsule which has been demonstrated to help maintain the skin's ability to protect against sun-related effects and aging. The result of research in photobiology at Harvard Medical School and European universities, Heliocare(R) is derived from a natural product which has been safely used in Europe for over 20 years and is currently sold in 13 countries. Heliocare(R) is not a sunscreen, but rather helps the body deal with the effects of UV that reaches the skin. It is recommended in addition to a sunscreen. Heliocare(R) is available from the pharmacy counter and at selected dermatologists' offices.

IVAX Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally.

Copies of this and other news releases may be obtained free of charge from IVAX's website at http://www.ivax.com.

Except for the historical matters contained herein, statements in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties which may affect the company's business and prospects, including the risks that the launch of Heliocare(R) capsules will be delayed; that Heliocare(R) capsules may not help maintain the skin's ability to protect against sun-related effects and aging; that Heliocare(R) capsules may not help the body deal with the effects of UV that reaches the skin; changing market conditions; the availability and cost of raw materials and other third party products; the impact of competitive products and pricing; and other risks and uncertainties based on economic, competitive, governmental, technological and other factors discussed in the Company's Annual Report on Form 10-K and its other filings with the Securities and Exchange Commission. Heliocare(R) is a registered trademark of Industrial Farmaceutica Cantabria, S.A.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish